Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IRBS

IR BioSciences (CE) (IRBS)

IR BioSciences Holdings Inc New (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:IRBS
DateTimeSourceHeadlineSymbolCompany
25/05/201107:28Edgar (US Regulatory)Annual Report (10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
17/05/201105:11Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
01/04/201103:54Edgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
11/03/201109:29Edgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
23/11/201008:12Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
13/11/201000:27Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
29/10/201000:00GlobeNewswire Inc.ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University CollaborationUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
02/10/201006:37Edgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
08/09/201021:00GlobeNewswire Inc.ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
01/09/201004:21GlobeNewswire Inc.ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for InUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
25/08/201023:00GlobeNewswire Inc.University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
24/08/201007:15Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
14/08/201006:12Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
05/08/201022:27Marketwired/ CORRECTION - ImmuneRegen BioSciencesUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/08/201021:00MarketwiredImmuneRegen BioSciences Completes Successful Reduction of DebtUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
26/07/201020:01Edgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
25/05/201005:40Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
18/05/201001:51Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
01/05/201007:17Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
27/04/201022:00MarketwiredImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen MeUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
21/04/201022:00MarketwiredImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead IndicaUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
20/04/201003:00MarketwiredImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic PlanningUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
16/04/201006:20Edgar (US Regulatory)Annual Report (10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
02/04/201007:01Edgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
05/03/201000:00MarketwiredImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary FiUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
11/02/201000:00MarketwiredFred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy CandidateUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
28/01/201000:00MarketwiredNational Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant CandidateUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
27/01/201006:54MarketwiredIR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active CompoundUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
06/01/201000:00MarketwiredImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic InfluenzaUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
25/12/200900:00MarketwiredImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development ContinuesUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
 Showing the most relevant articles for your search:USOTC:IRBS